Anti-pre-S2 antibody response in subjects vaccinated against hepatitis B and in naturally immunized subjects

Res Virol. 1991 Sep-Oct;142(5):363-71. doi: 10.1016/0923-2516(91)90003-l.

Abstract

Serum samples from individuals immunized with a pepsinized or non-pepsinized vaccine and from patients who had recovered from acute hepatitis B or who developed a chronic form of the disease, were analysed for the presence of antibody against the pre-S2 epitope of the hepatitis B virus. Anti-pre-S2 antibody was absent in all but one individual immunized with the pepsinized vaccine. Thirty-eight percent of the subjects who responded by anti-HBs production to the non-pepsinized preparation showed anti-pre-S2 antibody one year after complete vaccination. Among subjects who did not produce anti-HBs after immunization with this vaccine, 1 single individual produced anti-pre-S2 antibody. Anti-preS2 antibody was detectable after one year in 38% of the patients who recovered from acute hepatitis B, but in none of those with chronic hepatitis B. The kinetics of anti-pre-S2 antibody response to a booster injection was also analysed 1 month and 1 year after the 3rd injection and 1 month after the 4th injection of the non-pepsinized vaccine.

MeSH terms

  • Acute Disease
  • Chronic Disease
  • Follow-Up Studies
  • Hepatitis B / immunology
  • Hepatitis B / prevention & control*
  • Hepatitis B Antibodies / biosynthesis*
  • Hepatitis B Surface Antigens / immunology*
  • Hepatitis B Vaccines
  • Humans
  • Immunity, Innate*
  • Protein Precursors / immunology*
  • Vaccines, Synthetic
  • Viral Envelope Proteins / immunology
  • Viral Hepatitis Vaccines / immunology*

Substances

  • Hepatitis B Antibodies
  • Hepatitis B Surface Antigens
  • Hepatitis B Vaccines
  • Protein Precursors
  • Vaccines, Synthetic
  • Viral Envelope Proteins
  • Viral Hepatitis Vaccines
  • presurface protein 2, hepatitis B surface antigen